EFMC (@euromedchem) 's Twitter Profile
EFMC

@euromedchem

The official twitter feed of the European Federation for Medicinal Chemistry and Chemical Biology.

ID: 1179567576

linkhttp://www.efmc.info calendar_today14-02-2013 15:48:57

3,3K Tweet

4,4K Followers

762 Following

EFMC (@euromedchem) 's Twitter Profile Photo

📣 Session 21 – The next speaker is Dr Ian STANSFIELD who will talk about “Potent, Selective and Bioavailable Covalent Inhibitors of CDK7”. Keep following us! 🔬💡 #EFMCISMC24 #MedChem

📣 Session 21 – The next speaker is Dr Ian STANSFIELD who will talk about “Potent, Selective and Bioavailable Covalent Inhibitors of CDK7”. Keep following us! 🔬💡
#EFMCISMC24 #MedChem
EFMC (@euromedchem) 's Twitter Profile Photo

📣 Session 22 – The next speaker is Ms Sara CALENDA who will talk about “New Multitarget Agents for the Treatment of Demyelinating Diseases: A2A and A2B Adenosine Receptor Antagonists Hybridized with Antioxidants”. Keep following us! 🔬💡 #EFMCISMC24 #MedChem

📣 Session 22 – The next speaker is  Ms Sara CALENDA who will talk about “New Multitarget Agents for the Treatment of Demyelinating Diseases: A2A and A2B Adenosine Receptor Antagonists Hybridized with Antioxidants”. Keep following us! 🔬💡
#EFMCISMC24 #MedChem
EFMC (@euromedchem) 's Twitter Profile Photo

📣 Session 23 – The last speaker is Dr Shabnam SHAABANI who will talk about “Automated and Miniaturized Chemistry”. Keep following us! 🔬💡 #EFMCISMC24 #MedChem

📣 Session 23 – The last speaker is Dr Shabnam SHAABANI who will talk about “Automated and Miniaturized Chemistry”. Keep following us! 🔬💡
#EFMCISMC24 #MedChem
EFMC (@euromedchem) 's Twitter Profile Photo

📣 Session 22 – The last speaker is Dr. Magnus PFAFFENBACH Biogen who will talk about “Discovery of BIO-8169, a Highly Potent, Selective, and Brain Penetrant IRAK4 Inhibitor for the Treatment of Neuroinflammation”. Keep following us! 🔬💡 #EFMCISMC24 #MedChem

📣 Session 22 – The last speaker is  Dr. Magnus PFAFFENBACH <a href="/biogen/">Biogen</a> who will talk about “Discovery of BIO-8169, a Highly Potent, Selective, and Brain Penetrant IRAK4 Inhibitor for the Treatment of Neuroinflammation”. Keep following us! 🔬💡
#EFMCISMC24 #MedChem
EFMC (@euromedchem) 's Twitter Profile Photo

📣 Session 21 - Last but not least, Prof. Thomas BELL who will talk about "Protein Degradation Targeted by Selective ER Translocation Inhibitors; PD-L1 Down-Modulators as Anticancer Lead Compounds” #EFMCISMC24 #MedChem

📣 Session 21 - Last but not least, Prof. Thomas BELL who will talk about "Protein Degradation Targeted by Selective ER Translocation Inhibitors; PD-L1 Down-Modulators as Anticancer Lead Compounds” #EFMCISMC24 #MedChem
EFMC (@euromedchem) 's Twitter Profile Photo

📣Starting Session 26: New Technologies for Drug Delivery / EuChems Session chaired by Prof. Francesco PERI with a lecture from Dr Giuseppe BATTAGLIA on " Phenotypic Nanomedicines: from Drug Delivery to Supramolecular Drugs “. #EFMCISMC24 #MedChem

📣Starting Session 26: New Technologies for Drug Delivery / EuChems Session chaired by Prof. Francesco PERI with a lecture from Dr Giuseppe BATTAGLIA on " Phenotypic Nanomedicines: from Drug Delivery to Supramolecular Drugs “.
#EFMCISMC24 #MedChem
EFMC (@euromedchem) 's Twitter Profile Photo

📣Starting Session 25: "Late breaking news/Recent developments”. Session chaired by Dr Malin LEMURELL with a lecture from Ms Francesca BRUNELLI on “Isocyanide: the Game-Changer in Medicinal Chemistry” #EFMCISMC24

📣Starting Session 25: "Late breaking news/Recent developments”. Session chaired by Dr Malin LEMURELL with a lecture from Ms Francesca BRUNELLI on “Isocyanide: the Game-Changer in Medicinal Chemistry”
#EFMCISMC24
EFMC (@euromedchem) 's Twitter Profile Photo

📣 Session 25 – The next speaker is Dr Angela MACKAY who will talk about “The Discovery and Development of DFV890, a Clinical Phase Inhibitor of the NLRP3 Inflammasome”. Keep following us! 🔬💡 #EFMCISMC24 #MedChem

📣 Session 25 – The next speaker is Dr Angela MACKAY who will talk about “The Discovery and Development of DFV890, a Clinical Phase Inhibitor of the NLRP3 Inflammasome”. Keep following us! 🔬💡
#EFMCISMC24 #MedChem
EFMC (@euromedchem) 's Twitter Profile Photo

📣 Next speaker from Session 24 is Dr. Marco Borgogno from IAMA therapeutics: “Discovery, preclinical and clinical development of a selective NKCC1 inhibitor drug candidate for the treatment of core symptoms of brain disorders with defective NKCC1/KCC2 ratio”.

📣 Next speaker from Session 24 is Dr. Marco Borgogno from IAMA therapeutics: “Discovery, preclinical and clinical development of a selective NKCC1 inhibitor drug candidate for the treatment of core symptoms of brain disorders with defective NKCC1/KCC2 ratio”.
EFMC (@euromedchem) 's Twitter Profile Photo

📣 Session 25 – The next speaker is Dr Nuria DIAZ who will talk about “Discovery of Muvalaplin: the First Oral Molecule Inhibitor of Lp(a) Formation in Clinical Trials”. Keep following us! 🔬💡 #EFMCISMC24 #MedChem

📣 Session 25 – The next speaker is Dr Nuria DIAZ who will talk about “Discovery of Muvalaplin: the First Oral Molecule Inhibitor of Lp(a) Formation in Clinical Trials”. Keep following us! 🔬💡
#EFMCISMC24 #MedChem
EFMC (@euromedchem) 's Twitter Profile Photo

📣 We continue Session 24 with Prof. Klaus T. Wanner, who will speak about the synthesis and biological evaluation of GAT3 inhibitors related to (S)-SNAP5114 with an allostetic spacer.

📣 We continue Session 24 with Prof. Klaus T. Wanner, who will speak about the synthesis and biological evaluation of GAT3 inhibitors related to (S)-SNAP5114 with an allostetic spacer.
EFMC (@euromedchem) 's Twitter Profile Photo

📣 Session 26 – The next speaker is Dr. Anne MOORE who will talk about “Considerations for Stabilising and Administering Vaccines in Solid Dosage Forms”. Keep following us! 🔬💡 #EFMCISMC24 #MedChem

📣 Session 26 – The next speaker is  Dr. Anne MOORE who will talk about “Considerations for Stabilising and Administering Vaccines in Solid Dosage Forms”. Keep following us! 🔬💡
#EFMCISMC24 #MedChem
EFMC (@euromedchem) 's Twitter Profile Photo

📣 Session 25 – Last speaker is Dr Matthias HOFFMANN who will talk about “Discovery of Highly Selective SYK Inhibitors BI 894416 and BI 1342561 to Treat Severe Asthma” #EFMCISMC24 #MedChem

📣 Session 25 – Last speaker is Dr Matthias HOFFMANN who will talk about “Discovery of Highly Selective SYK Inhibitors BI 894416 and BI 1342561 to Treat Severe Asthma”
#EFMCISMC24 #MedChem
EFMC (@euromedchem) 's Twitter Profile Photo

📣 Session 26 – The current speaker is Dr Elena M SÁNCHEZ-FERNÁNDEZ who will talk about “Exploiting yhe Synergy between Immuno-Glyco-Compounds and Nanoplatforms Based on Metal-Organic Networks against Diabetic Retinopathy”. Keep following us! 🔬💡 #EFMCISMC24 #MedChem

📣 Session 26 – The current speaker is  Dr Elena M SÁNCHEZ-FERNÁNDEZ  who will talk about “Exploiting yhe Synergy between Immuno-Glyco-Compounds and Nanoplatforms Based on Metal-Organic Networks against Diabetic Retinopathy”. Keep following us! 🔬💡
#EFMCISMC24 #MedChem
EFMC (@euromedchem) 's Twitter Profile Photo

📣 The last speaker of session 24 is Dr Nina Compagne, the winner of last year’s YMCS from the EFMC Young Scientists Network. She will speak about boosting antibiotics: development of bacterial efflux pump inhibitors to overcome antimicrobial resistance in enterobacterales. #EFMCISMC2024 #MedChem

📣 The last speaker of session 24 is Dr Nina Compagne, the winner of last year’s YMCS from the <a href="/YoungSciNet/">EFMC Young Scientists Network</a>. She will speak about boosting antibiotics: development of bacterial efflux pump inhibitors to overcome antimicrobial resistance in enterobacterales.
#EFMCISMC2024 #MedChem
EFMC (@euromedchem) 's Twitter Profile Photo

📣 Session 26 – The last speaker of the session is Ms Paraskevi Kleio ANASTASIOU who will talk about “MCR-Based Lipidoids”. Keep following us! 🔬💡 #EFMCISMC24 #MedChem

📣 Session 26 – The last speaker of the session is  Ms Paraskevi Kleio ANASTASIOU  who will talk about “MCR-Based Lipidoids”. Keep following us! 🔬💡
#EFMCISMC24 #MedChem
EFMC (@euromedchem) 's Twitter Profile Photo

🚀 Don't miss the closing lecture of EFMC-ISMC 2024! 🌟 Now in #EFMCISMC24 Join us in the lecture "A Career Doing STUFF" given by Dr. Mike HANN GSK, presented by Chair Prof. György KESERU. Be part of this insightful session! #EFMCISMC2024 #MedicinalChemistry

🚀 Don't miss the closing lecture of EFMC-ISMC 2024! 🌟 Now in #EFMCISMC24
Join us in the lecture "A Career Doing STUFF" given by Dr. Mike HANN <a href="/GSK/">GSK</a>, presented by Chair Prof. György KESERU.
Be part of this insightful session! #EFMCISMC2024 #MedicinalChemistry
ChemMedChem (@chemmedchem) 's Twitter Profile Photo

Mike Hann @gsk reminds us "Intelligence Amplification" > "Artificial Intelligence" (F. Brooks). "If you're using the term #AI & believe its intelligence, then challenge it, question it, and don't bow down to it... Don't suddenly expect AI to solve problems." #EFMCISMC24 #compchem

Mike Hann @gsk reminds us "Intelligence Amplification" &gt; "Artificial Intelligence" (F. Brooks). "If you're using the term #AI &amp; believe its intelligence, then challenge it, question it, and don't bow down to it... Don't suddenly expect AI to solve problems." #EFMCISMC24 #compchem
EFMC (@euromedchem) 's Twitter Profile Photo

🏆Wrapping up #EFMCISMC24 with Poster Prizes announced by Ly Differding and closing remarks from Roberto Di Santo. 🌟 Huge thanks to all speakers, attendees, and organizers for making this event a success. We're excited to welcome you #EFMCASMC25 and #EFMCISMC26 #MedicinalChemistry🏆

🏆Wrapping up #EFMCISMC24 with Poster Prizes announced by <a href="/Lydiff/">Ly Differding</a> and closing remarks from <a href="/RobertoDiSanto7/">Roberto Di Santo</a>. 🌟 Huge thanks to all speakers, attendees, and organizers for making this event a success. We're excited to welcome you #EFMCASMC25 and #EFMCISMC26  #MedicinalChemistry🏆